Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Vildagliptin, ATC A10BH02

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 05, 2026 · 50 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Vildagliptin, ATC A10BH02

55/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

55 / 100

Complexity

20 / 100

Risk factors

The open-house agreements automatically expire if a competitive rebate contract (national or regional) for Vildagliptin...

The agreements are non-exclusive and do not ensure any sales volume; they only provide a rebate framework. Actual sales...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Non-exclusive rebate agreements for Vildagliptin (ATC A10BH02) for AOK Bayern.
  • All eligible pharmaceutical companies can participate; no selection process.
Show full summary

AOK Bayern is implementing a non-exclusive open-house model for pharmaceutical rebate agreements for the active ingredient Vildagliptin (ATC A10BH02) under §130a Abs. 8 SGB V. All qualified pharmaceutical companies can enter into identical, non-negotiable rebate agreements. The earliest contract start is 01.12.2024, all agreements end 30.11.2026. Joining is possible any time until 05.10.2026. The procedure is not subject to public procurement law; it is a voluntary open-house model with no selection of contractors. Only pharmaceutical companies are eligible. Submission requires a signed self-declaration of reliability and the signed contract with annex. Documents can be submitted in paper (2 copies) or electronically with qualified electronic signature. The buyer is AOK Bayern. No estimated value is provided. Award criteria are not applicable as all eligible participants are accepted.

Risks

The open-house agreements automatically expire if a competitive rebate contract (national or regional) for Vildagliptin...

The agreements are non-exclusive and do not ensure any sales volume; they only provide a rebate framework. Actual sales...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Signed contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' required.

Eligibility

  • Only pharmaceutical companies are eligible (potential contractors).

Administrative

  • Signed self-declaration of reliability must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Vildagliptin, ATC A10BH02

Open-house model for non-exclusive rebate agreements for Vildagliptin (ATC A10BH02) to be concluded with any interested pharmaceutical company that meets the eligibility criteria. Agreements are identical and non-negotiable. Contract period: 01.12.2024 to 30.11.2026.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Nov 2024 - Nov 2026

Category

Pharmaceutical products

Deadline

Deadline Oct 05, 2026

Procurement Details

Publication date
16 Oct 2024
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
628246-2024

Documents (2)

Similar tenders